Related Experiment Video

Updated: Feb 7, 2026

GPI Anchoring of Proteins in the ER Membrane
01:29

GPI Anchoring of Proteins in the ER Membrane

5.6K

Farnesyl transferase inhibitors: a novel targeted tnerapy for cancer

S R Johnston1

  • 1Royal Marsden Hospital and Institute of Cancer Research, London, UK. stephen@icr.ac.uk

The Lancet. Oncology
|March 22, 2002
PubMed

Insights

Farnesyl transferase inhibitors show promise as anticancer drugs, targeting not only RAS-mutated cancers but also others. Clinical trials reveal encouraging results, highlighting their potential as a new cancer therapy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Activating oncogenic RAS gene mutations are prevalent in 30% of adult solid tumors.
  • Farnesyl transferase inhibitors (FTIs) were initially designed to block RAS-transformed cell signaling.
  • Emerging research indicates FTIs may also be effective against cancers lacking RAS mutations.

Purpose of the Study:

  • To explore the therapeutic potential of farnesyl transferase inhibitors in cancer treatment.
  • To investigate the efficacy of FTIs beyond RAS-mutated tumors.
  • To address challenges in the clinical development of FTIs.

Main Methods:

  • Review of biological effects of farnesyl transferase inhibitors on cancer cells.
  • Analysis of data from Phase I and II clinical trials.

Main Results:

  • Encouraging outcomes observed in Phase I and II clinical trials.
  • Demonstrated potential of FTIs in targeting a broader range of tumors than initially anticipated.
  • Identification of new therapeutic opportunities for FTI-based cancer treatments.

Conclusions:

  • Farnesyl transferase inhibitors represent a promising new class of anticancer drugs.
  • The therapeutic application of FTIs extends to cancers with and without oncogenic RAS mutations.
  • Further clinical development is warranted to optimize the use of FTIs in oncology.

More Related Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

1.3K
The Anchoring-and-Adjustment Heuristic: Judgement and Biases01:25

The Anchoring-and-Adjustment Heuristic: Judgement and Biases

7.8K

Related Concept Videos

GPI Anchoring of Proteins in the ER Membrane01:29

GPI Anchoring of Proteins in the ER Membrane

GPI-anchoring is a post-translational, reversible protein modification that is ubiquitous in eukaryotes. Such proteins are primarily present on the exoplasmic leaflet of the plasma membrane.
GPI-anchor structure
A sequence of 11 enzymatic reactions results in the synthesis of the complete GPI anchor consisting of a hydrophobic and a hydrophilic portion. The hydrophobic portion comprises phosphatidylinositol, while the hydrophilic part comprises polar groups like phosphoethanolamine,...
5.6K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.3K
The Anchoring-and-Adjustment Heuristic01:25

The Anchoring-and-Adjustment Heuristic

In order to make good decisions, we use our knowledge and our reasoning. Often, this knowledge and reasoning is sound and solid. However, sometimes, we are swayed by biases or by others manipulating a situation. For example, let’s say you and three friends wanted to rent a house and had a combined target budget of $1,600. The realtor shows you only very run-down houses for $1,600 and then shows you a very nice house for $2,000. Might you ask each person to pay more in rent to get the...
7.8K
Anchoring Junctions01:03

Anchoring Junctions

Anchoring junctions are multiprotein complexes that help cells connect to other cells and the extracellular matrix. Anchoring junctions are present on the lateral and basal surfaces of cells, providing strong and flexible connections. Focal adhesions are often formed due to cell interactions with the ECM substrata, which initiate signal transduction via kinase cascades and other mechanisms. Together, they provide stability and tissue integrity. There are three types of anchoring junctions:...
5.0K
Lipids as Anchors01:32

Lipids as Anchors

In the plasma membrane, the lipids forming the bilayer can also act as an anchor to tether proteins to the membrane. The three main types of lipid anchors found in eukaryotes are – prenyl groups, fatty acyl groups, and glycosylphosphatidylinositol or GPI groups. Prenyl and fatty acyl groups act as anchors on the cytosolic surface of the membrane, whereas GPI anchors proteins on the extracellular side.
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...
7.4K
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
10.8K